G M. Anantharamaiah - Publications

Affiliations: 
1982- University of Alabama, Birmingham, Birmingham, AL, United States 
Area:
Biochemistry, structural biology, molecular biology, pathology
Website:
http://www.norc.uab.edu/people/ganantharamaiah

224 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Krishnarjuna B, Sharma G, Im SC, Auchus R, Anantharamaiah GM, Ramamoorthy A. Characterization of nanodisc-forming peptides for membrane protein studies. Journal of Colloid and Interface Science. 653: 1402-1414. PMID 37801850 DOI: 10.1016/j.jcis.2023.09.162  0.416
2022 White CR, Palgunachari M, Wolkowicz P, Anantharamaiah GM. Peptides as Therapeutic Agents for Atherosclerosis. Methods in Molecular Biology (Clifton, N.J.). 2419: 89-110. PMID 35237960 DOI: 10.1007/978-1-0716-1924-7_6  0.483
2021 Krishnarjuna B, Yamazaki T, Anantharamaiah GM, Ramamoorthy A. Nanodisc reconstitution of flavin mononucleotide binding domain of cytochrome-P450-reductase enables high-resolution NMR probing. Chemical Communications (Cambridge, England). 57: 4819-4822. PMID 33982687 DOI: 10.1039/d1cc01018b  0.265
2021 Wolkowicz P, White CR, Anantharamaiah GM. Apolipoprotein Mimetic Peptides: An Emerging Therapy against Diabetic Inflammation and Dyslipidemia. Biomolecules. 11. PMID 33922449 DOI: 10.3390/biom11050627  0.397
2020 Hamid T, Ismahil MA, Bansal SS, Patel B, Goel M, White CR, Anantharamaiah GM, Prabhu SD. The Apolipoprotein A-I Mimetic L-4F Attenuates Monocyte Activation and Adverse Cardiac Remodeling after Myocardial Infarction. International Journal of Molecular Sciences. 21. PMID 32429244 DOI: 10.3390/Ijms21103519  0.419
2020 Bai J, Wang J, Ravula T, Im SC, Anantharamaiah GM, Waskell L, Ramamoorthy A. Expression, purification, and functional reconstitution of F-labeled cytochrome b5 in peptide nanodiscs for NMR studies. Biochimica Et Biophysica Acta. Biomembranes. 183194. PMID 31953231 DOI: 10.1016/J.Bbamem.2020.183194  0.48
2019 Mishra VK, Anantharamaiah GM. High-Resolution Structural Studies Elucidate Antiatherogenic and Anti-Inflammatory Properties of Peptides Designed to Mimic Amphipathic α-Helical Domains of Apolipoprotein A-I. Natural Product Communications. 14. PMID 32864035 DOI: 10.1177/1934578X19849131  0.567
2019 Sahoo BR, Bekier ME, Liu Z, Kocman V, Stoddard AK, Anantharamaiah GM, Nowick J, Fierke CA, Wang Y, Ramamoorthy A. Structural Interaction of Apolipoprotein A-I Mimetic Peptide with Amyloid-β Generates Toxic Hetero-oligomers. Journal of Molecular Biology. PMID 31866295 DOI: 10.1016/J.Jmb.2019.12.005  0.432
2019 Gentry KA, Anantharamaiah GM, Ramamoorthy A. Probing protein-protein and protein-substrate interactions in the dynamic membrane-associated ternary complex of cytochromes P450, b, and reductase. Chemical Communications (Cambridge, England). PMID 31638629 DOI: 10.1039/C9Cc05904K  0.368
2019 Meriwether D, Sulaiman D, Volpe C, Dorfman A, Grijalva V, Dorreh N, Solorzano-Vargas RS, Wang J, O'Connor E, Papesh J, Larauche M, Trost H, Palgunachari MN, Anantharamaiah GM, Herschman HR, et al. Apolipoprotein A-I mimetics mitigate intestinal inflammation in COX2-dependent inflammatory bowel disease model. The Journal of Clinical Investigation. 130. PMID 31184596 DOI: 10.1172/Jci123700  0.448
2019 Mahajan M, Ravula T, Prade E, Anantharamaiah GM, Ramamoorthy A. Probing membrane enhanced protein-protein interactions in a minimal redox complex of cytochrome-P450 and P450-reductase. Chemical Communications (Cambridge, England). PMID 31041432 DOI: 10.1039/C9Cc01630A  0.357
2019 Salnikov ES, Aisenbrey C, Anantharamaiah GM, Bechinger B. Corrigendum to "Solid-state NMR structural investigations of peptide-based nanodiscs and of transmembrane helices in bicellar arrangements" [Chem. Phys. Lipids 219 (2019) 58-71]. Chemistry and Physics of Lipids. 221: 219. PMID 31036256 DOI: 10.1016/J.Chemphyslip.2019.04.006  0.508
2019 Tsuchida Y, Zhong J, Otsuka T, Dikalova A, Pastan I, Anantharamaiah GM, Linton MF, Yancey PG, Ikizler TA, Fogo AB, Yang H, Kon V. Lipoprotein modulation of proteinuric renal injury. Laboratory Investigation; a Journal of Technical Methods and Pathology. PMID 31019291 DOI: 10.1038/S41374-019-0253-6  0.436
2019 Salnikov ES, Aisenbrey C, Anantharamaiah GM, Bechinger B. Solid-state NMR structural investigations of peptide-based nanodiscs and of transmembrane helices in bicellar arrangements. Chemistry and Physics of Lipids. 219: 58-71. PMID 30711343 DOI: 10.1016/J.Chemphyslip.2019.01.012  0.525
2019 White CR, Datta G, Wilson L, Palgunachari MN, Anantharamaiah GM. The ApoA-I Mimetic Peptide 4F Protects Apolipoprotein A-I From Oxidative Damage. Chemistry and Physics of Lipids. PMID 30707910 DOI: 10.1016/J.Chemphyslip.2019.01.009  0.525
2019 He Y, Song HD, Anantharamaiah GM, Palgunachari MN, Bornfeldt K, Segrest JP, Heinecke J. Apolipoprotein A1 forms 5/5 and 5/4 antiparallel dimers in human high-density lipoprotein. Molecular & Cellular Proteomics : McP. PMID 30659061 DOI: 10.1074/Mcp.Ra118.000878  0.466
2018 Anantharamaiah GM, Garber DW, Goldberg D, Morrell E, Datta G, Palgunachari M, Register TC, Appt SE, White CR. Novel Fatty Acyl ApoE Mimetic Peptides Have Increased Potency To Reduce Plasma Cholesterol In Mice And Macaques. Journal of Lipid Research. PMID 30201630 DOI: 10.1194/Jlr.M085985  0.564
2018 Sahoo BR, Genjo T, Cox SJ, Stoddard AK, Anantharamaiah GM, Fierke C, Ramamoorthy A. Nanodisc-Forming Scaffold Protein Promoted Retardation of Amyloid-Beta Aggregation. Journal of Molecular Biology. PMID 30170005 DOI: 10.1016/J.Jmb.2018.08.018  0.507
2018 Salnikov ES, Anantharamaiah GM, Bechinger B. Supramolecular Organization of Apolipoprotein-A-I-Derived Peptides within Disc-like Arrangements. Biophysical Journal. 115: 467-477. PMID 30054032 DOI: 10.1016/J.Bpj.2018.06.026  0.545
2018 Giordano-Mooga S, Datta G, Wolkowicz P, Garber DW, Palgunachari M, White CR, Anantharamaiah GM. The Apolipoprotein E Mimetic Peptide AEM-2 Attenuates Mitochondrial Injury And Apoptosis In Human THP-1 Macrophages. Current Topics in Peptide & Protein Research. 19: 15-25. PMID 29955206  0.41
2018 Barnaba C, Ravula T, Medina-Meza IG, Im SC, Anantharamaiah GM, Waskell L, Ramamoorthy A. Lipid-exchange in nanodiscs discloses membrane boundaries of cytochrome-P450 reductase. Chemical Communications (Cambridge, England). PMID 29863198 DOI: 10.1039/C8Cc02003E  0.45
2018 Prade E, Mahajan M, Im SC, Zhang M, Anantharamaiah GM, Waskell L, Ramamoorthy A. A Minimal Functional Complex of Cytochrome P450 and FBD of Cytochrome P450 Reductase in Nanodiscs. Angewandte Chemie (International Ed. in English). PMID 29722926 DOI: 10.1002/Anie.201802210  0.395
2018 Barnaba C, Sahoo BR, Ravula T, Medina-Meza IG, Im SC, Anantharamaiah GM, Waskell L, Ramamoorthy A. Cytochrome-P450-Induced Ordering of Microsomal Membranes Modulates Affinity for Drugs. Angewandte Chemie (International Ed. in English). 57: 3391-3395. PMID 29385304 DOI: 10.1002/Anie.201713167  0.447
2018 Ravula T, Ishikuro D, Kodera N, Ando T, Anantharamaiah GM, Ramamoorthy A. Real-Time Monitoring of Lipid Exchange via Fusion of Peptide Based Lipid-Nanodiscs Chemistry of Materials. 30: 3204-3207. DOI: 10.1021/Acs.Chemmater.8B00946  0.486
2017 Ravula T, Barnaba C, Mahajan M, Anantharamaiah GM, Im SC, Waskell L, Ramamoorthy A. Membrane environment drives cytochrome P450's spin transition and its interaction with cytochrome b. Chemical Communications (Cambridge, England). 53: 12798-12801. PMID 29143058 DOI: 10.1039/C7Cc07520K  0.346
2017 Rudolf M, Mir Mohi Sefat A, Miura Y, Tura A, Raasch W, Ranjbar M, Grisanti S, Aherrahrou Z, Wagner A, Messinger JD, Garber DW, Anantharamaiah GM, Curcio CA. ApoA-I Mimetic Peptide 4F Reduces Age-Related Lipid Deposition in Murine Bruch's Membrane and Causes Its Structural Remodeling. Current Eye Research. 1-12. PMID 28972410 DOI: 10.1080/02713683.2017.1370118  0.5
2017 Gentry KA, Prade E, Barnaba C, Zhang M, Mahajan M, Im SC, Anantharamaiah GM, Nagao S, Waskell L, Ramamoorthy A. Kinetic and Structural Characterization of the Effects of Membrane on the Complex of Cytochrome band Cytochrome c. Scientific Reports. 7: 7793. PMID 28798301 DOI: 10.1038/S41598-017-08130-7  0.392
2017 White CR, Anantharamaiah GM. Cholesterol reduction and macrophage function: role of paraoxonases. Current Opinion in Lipidology. PMID 28742600 DOI: 10.1097/Mol.0000000000000444  0.454
2016 Anantharamaiah GM, Garber DW, White CR. Apolipoprotein Mimetic Peptides as Modulators of Lipoprotein Function. Protein and Peptide Letters. PMID 27586181 DOI: 10.2174/0929866523666160901154216  0.578
2016 White CR, Giordano S, Anantharamaiah GM. High-density lipoprotein, mitochondrial dysfunction and cell survival mechanisms. Chemistry and Physics of Lipids. PMID 27150975 DOI: 10.1016/J.Chemphyslip.2016.04.007  0.361
2016 Anantharamaiah GM. Apolipoprotein E mimetic: From theory to therapy Journal of Clinical & Experimental Cardiology. 7. DOI: 10.4172/2155-9880.C1.029  0.201
2016 Giordano S, Datta G, Varambally S, Anantharamaiah GM, White CR. Anti-Inflammatory Effects of Apolipoprotein E Mimetics Peptides in THP-1 Human Macrophages Free Radical Biology and Medicine. 100. DOI: 10.1016/J.Freeradbiomed.2016.10.145  0.521
2015 White CR, Goldberg DI, Anantharamaiah GM. Recent developments in modulating atherogenic lipoproteins. Current Opinion in Lipidology. 26: 369-75. PMID 26270809 DOI: 10.1097/Mol.0000000000000216  0.469
2015 Chattopadhyay A, Grijalva V, Hough G, Su F, Mukherjee P, Farias-Eisner R, Anantharamaiah GM, Faull KF, Hwang LH, Navab M, Fogelman AM, Reddy ST. Efficacy of tomato concentrates in mouse models of dyslipidemia and cancer. Pharmacology Research & Perspectives. 3: e00154. PMID 26171234 DOI: 10.1002/Prp2.154  0.43
2015 Anantharamaiah G, Goldberg D. Novel method for reducing plasma cholesterol: a ligand replacement therapy. Clinical Lipidology. 10: 83-90. PMID 25937835 DOI: 10.2217/Clp.14.63  0.458
2015 Datta G, Kramer PA, Johnson MS, Sawada H, Smythies LE, Crossman DK, Chacko B, Ballinger SW, Westbrook DG, Mayakonda P, Anantharamaiah GM, Darley-Usmar VM, White CR. Bioenergetic programming of macrophages by the apolipoprotein A-I mimetic peptide 4F. The Biochemical Journal. 467: 517-27. PMID 25742174 DOI: 10.1042/Bj20131635  0.44
2015 Navab M, Chattopadhyay A, Hough G, Meriwether D, Fogelman SI, Wagner AC, Grijalva V, Su F, Anantharamaiah GM, Hwang LH, Faull KF, Reddy ST, Fogelman AM. Source and role of intestinally derived lysophosphatidic acid in dyslipidemia and atherosclerosis. Journal of Lipid Research. 56: 871-87. PMID 25646365 DOI: 10.1194/Jlr.M056614  0.562
2014 Hutchins PM, Ronsein GE, Monette JS, Pamir N, Wimberger J, He Y, Anantharamaiah GM, Kim DS, Ranchalis JE, Jarvik GP, Vaisar T, Heinecke JW. Quantification of HDL particle concentration by calibrated ion mobility analysis. Clinical Chemistry. 60: 1393-401. PMID 25225166 DOI: 10.1373/Clinchem.2014.228114  0.424
2014 White CR, Garber DW, Anantharamaiah GM. Anti-inflammatory and cholesterol-reducing properties of apolipoprotein mimetics: A review Journal of Lipid Research. 55: 2007-2021. PMID 25157031 DOI: 10.1194/Jlr.R051367  0.505
2014 Reddy ST, Navab M, Anantharamaiah GM, Fogelman AM. Apolipoprotein A-I mimetics. Current Opinion in Lipidology. 25: 304-308. PMID 24977978 DOI: 10.1097/Mol.0000000000000092  0.433
2014 Sharifov OF, Xu X, Gaggar A, Tabengwa EM, White CR, Palgunachari MN, Anantharamaiah GM, Gupta H. L-4F inhibits lipopolysaccharide-mediated activation of primary human neutrophils. Inflammation. 37: 1401-12. PMID 24647607 DOI: 10.1007/S10753-014-9864-7  0.438
2014 Reddy ST, Navab M, Anantharamaiah GM, Fogelman AM. Searching for a successful HDL-based treatment strategy. Biochimica Et Biophysica Acta. 1841: 162-7. PMID 24466591  0.421
2014 Sharifov OF, Nayyar G, Ternovoy VV, Palgunachari MN, Garber DW, Anantharamaiah G, Gupta H. Comparison of anti-endotoxin activity of apoE and apoA mimetic derivatives of a model amphipathic peptide 18A. Innate Immunity. 20: 867-80. PMID 24323453 DOI: 10.1177/1753425913514621  0.522
2014 Sharifov OF, Nayyar G, Ternovoy VV, Palgunachari MN, Garber DW, Anantharamaiah GM, Gupta H. Comparison of anti-endotoxin activity of apoE and apoA mimetic derivatives of a model amphipathic peptide 18A Innate Immunity. 20: 867-880. DOI: 10.1177/1753425913514621  0.445
2014 Reddy ST, Navab M, Anantharamaiah GM, Fogelman AM. Searching for a successful HDL-based treatment strategy. Biochimica Et Biophysica Acta. 1841: 162-167. DOI: 10.1016/J.Bbalip.2013.10.012  0.502
2013 Navab M, Hough G, Buga GM, Su F, Wagner AC, Meriwether D, Chattopadhyay A, Gao F, Grijalva V, Danciger JS, Van Lenten BJ, Org E, Lusis AJ, Pan C, Anantharamaiah GM, et al. Transgenic 6F tomatoes act on the small intestine to prevent systemic inflammation and dyslipidemia caused by Western diet and intestinally derived lysophosphatidic acid. Journal of Lipid Research. 54: 3403-18. PMID 24085744 DOI: 10.1194/Jlr.M042051  0.438
2013 Sharifov OF, Nayyar G, Ternovoy VV, Mishra VK, Litovsky SH, Palgunachari MN, Garber DW, Anantharamaiah GM, Gupta H. Cationic peptide mR18L with lipid lowering properties inhibits LPS-induced systemic and liver inflammation in rats. Biochemical and Biophysical Research Communications. 436: 705-10. PMID 23791744 DOI: 10.1016/J.Bbrc.2013.06.020  0.461
2013 Sharifov OF, Xu X, Gaggar A, Grizzle WE, Mishra VK, Honavar J, Litovsky SH, Palgunachari MN, White CR, Anantharamaiah GM, Gupta H. Anti-inflammatory mechanisms of apolipoprotein A-I mimetic peptide in acute respiratory distress syndrome secondary to sepsis. Plos One. 8: e64486. PMID 23691230 DOI: 10.1371/Journal.Pone.0064486  0.5
2013 Handattu SP, Monroe CE, Nayyar G, Palgunachari MN, Kadish I, van Groen T, Anantharamaiah GM, Garber DW. In vivo and in vitro effects of an apolipoprotein e mimetic peptide on amyloid-β pathology. Journal of Alzheimer's Disease : Jad. 36: 335-47. PMID 23603398 DOI: 10.3233/Jad-122377  0.528
2013 Chattopadhyay A, Navab M, Hough G, Gao F, Meriwether D, Grijalva V, Springstead JR, Palgnachari MN, Namiri-Kalantari R, Su F, Van Lenten BJ, Wagner AC, Anantharamaiah GM, Farias-Eisner R, Farias-Eisener R, et al. A novel approach to oral apoA-I mimetic therapy. Journal of Lipid Research. 54: 995-1010. PMID 23378594 DOI: 10.1194/Jlr.M033555  0.451
2013 Mishra VK, Palgunachari MN, McPherson DT, Anantharamaiah GM. Lipid complex of apolipoprotein A-I mimetic peptide 4F is a novel platform for paraoxonase-1 binding and enhancing its activity and stability. Biochemical and Biophysical Research Communications. 430: 975-80. PMID 23261466 DOI: 10.1016/J.Bbrc.2012.11.128  0.492
2013 Handattu SP, Nayyar G, Garber DW, Palgunachari MN, Monroe CE, Keenum TD, Mishra VK, Datta G, Anantharamaiah GM. Two apolipoprotein E mimetic peptides with similar cholesterol reducing properties exhibit differential atheroprotective effects in LDL-R null mice Atherosclerosis. 227: 58-64. PMID 23159231 DOI: 10.1016/J.Atherosclerosis.2012.10.064  0.549
2013 Anantharamaiah GM, Garber DW. Recent progress in the development of apoA-I and apoE mimetic therapies Clinical Lipidology. 8: 265-268. DOI: 10.2217/Clp.13.17  0.449
2012 White CR, Smythies LE, Crossman DK, Palgunachari MN, Anantharamaiah GM, Datta G. Regulation of pattern recognition receptors by the apolipoprotein A-I mimetic peptide 4F. Arteriosclerosis, Thrombosis, and Vascular Biology. 32: 2631-9. PMID 22982462 DOI: 10.1161/Atvbaha.112.300167  0.451
2012 Nayyar G, Garber DW, Palgunachari MN, Monroe CE, Keenum TD, Handattu SP, Mishra VK, Anantharamaiah GM. Apolipoprotein E mimetic is more effective than apolipoprotein A-I mimetic in reducing lesion formation in older female apo E null mice Atherosclerosis. 224: 326-331. PMID 22771190 DOI: 10.1016/J.Atherosclerosis.2012.05.040  0.521
2012 White CR, Datta G, Buck AK, Chaddha M, Reddy G, Wilson L, Palgunachari MN, Abbasi M, Anantharamaiah GM. Preservation of biological function despite oxidative modification of the apolipoprotein A-I mimetic peptide 4F. Journal of Lipid Research. 53: 1576-87. PMID 22589558 DOI: 10.1194/Jlr.M026278  0.493
2012 Nayyar G, Mishra VK, Handattu SP, Palgunachari MN, Shin R, McPherson DT, Deivanayagam CC, Garber DW, Segrest JP, Anantharamaiah GM. Sidedness of interfacial arginine residues and anti-atherogenicity of apolipoprotein A-I mimetic peptides. Journal of Lipid Research. 53: 849-58. PMID 22377531 DOI: 10.1194/Jlr.M019844  0.55
2012 Navab M, Reddy ST, Anantharamaiah GM, Hough GP, Buga GM, Danciger J, Fogelman AM. D-4F-mediated reduction in metabolites of arachidonic and linoleic acids in the small intestine is associated with decreased inflammation in low-density lipoprotein receptor-null mice Journal of Lipid Research. 53: 437-445. PMID 22167743 DOI: 10.1194/Jlr.M023523  0.539
2012 Ganapathy E, Su F, Meriwether D, Devarajan A, Grijalva V, Gao F, Chattopadhyay A, Anantharamaiah GM, Navab M, Fogelman AM, Reddy ST, Farias-Eisner R. D-4F, an apoA-I mimetic peptide, inhibits proliferation and tumorigenicity of epithelial ovarian cancer cells by upregulating the antioxidant enzyme MnSOD. International Journal of Cancer. Journal International Du Cancer. 130: 1071-81. PMID 21425255 DOI: 10.1002/Ijc.26079  0.472
2011 Datta G, Gupta H, Zhang Z, Mayakonda P, Anantharamaiah GM, White CR. HDL Mimetic Peptide Administration Improves Left Ventricular Filling and Cardiac output in Lipopolysaccharide-Treated Rats. Journal of Clinical & Experimental Cardiology. 2. PMID 23227448 DOI: 10.4172/2155-9880.1000172  0.454
2011 Sharifov OF, Nayyar G, Garber DW, Handattu SP, Mishra VK, Goldberg D, Anantharamaiah GM, Gupta H. Apolipoprotein E mimetics and cholesterol-lowering properties American Journal of Cardiovascular Drugs. 11: 371-381. PMID 22149316 DOI: 10.2165/11594190-000000000-00000  0.576
2011 Meriwether D, Imaizumi S, Grijalva V, Hough G, Vakili L, Anantharamaiah GM, Farias-Eisner R, Navab M, Fogelman AM, Reddy ST, Shechter I. Enhancement by LDL of transfer of L-4F and oxidized lipids to HDL in C57BL/6J mice and human plasma Journal of Lipid Research. 52: 1795-1809. PMID 21804067 DOI: 10.1194/Jlr.M016741  0.484
2011 Navab M, Reddy ST, Anantharamaiah GM, Imaizumi S, Hough G, Hama S, Fogelman AM. Intestine may be a major site of action for the apoA-I mimetic peptide 4F whether administered subcutaneously or orally Journal of Lipid Research. 52: 1200-1210. PMID 21444758 DOI: 10.1194/Jlr.M013144  0.511
2011 Gao F, Vasquez SX, Su F, Roberts S, Shah N, Grijalva V, Imaizumi S, Chattopadhyay A, Ganapathy E, Meriwether D, Johnston B, Anantharamaiah GM, Navab M, Fogelman AM, Reddy ST, et al. L-5F, an apolipoprotein A-I mimetic, inhibits tumor angiogenesis by suppressing VEGF/basic FGF signaling pathways. Integrative Biology : Quantitative Biosciences From Nano to Macro. 3: 479-89. PMID 21283904 DOI: 10.1039/C0Ib00147C  0.436
2011 Bashtovyy D, Jones MK, Anantharamaiah GM, Segrest JP. Sequence conservation of apolipoprotein A-I affords novel insights into HDL structure-function. Journal of Lipid Research. 52: 435-450. PMID 21159667 DOI: 10.1194/Jlr.R012658  0.452
2011 Mishra VK, Palgunachari MN, Hudson JS, Shin R, Keenum TD, Krishna NR, Anantharamaiah GM. Structure and lipid interactions of an anti-inflammatory and anti-atherogenic 10-residue class G(*) apolipoprotein J peptide using solution NMR. Biochimica Et Biophysica Acta. 1808: 498-507. PMID 20970404 DOI: 10.1016/J.Bbamem.2010.10.011  0.548
2010 Su F, Kozak KR, Imaizumi S, Gao F, Amneus MW, Grijalva V, Ng C, Wagner A, Hough G, Farias-Eisner G, Anantharamaiah GM, Lenten BJV, Navab M, Fogelman AM, Reddy ST, et al. Apolipoprotein A-I (apoA-I) and apoA-I mimetic peptides inhibit tumor development in a mouse model of ovarian cancer Proceedings of the National Academy of Sciences of the United States of America. 107: 19997-20002. PMID 21041624 DOI: 10.1073/Pnas.1009010107  0.471
2010 Nayyar G, Handattu SP, Monroe CE, Chaddha M, Datta G, Mishra VK, Keenum TD, Palgunachari MN, Garber DW, Anantharamaiah GM. Two adjacent domains (141-150 and 151-160) of apoE covalently linked to a class A amphipathic helical peptide exhibit opposite atherogenic effects Atherosclerosis. 213: 449-457. PMID 21030022 DOI: 10.1016/J.Atherosclerosis.2010.09.030  0.513
2010 Handattu SP, Datta G, Epand RM, Epand RF, Palgunachari MN, Mishra VK, Monroe CE, Keenum TD, Chaddha M, Anantharamaiah GM, Garber DW. Oral administration of L-mR18L, a single domain cationic amphipathic helical peptide, inhibits lesion formation in ApoE null mice Journal of Lipid Research. 51: 3491-3499. PMID 20841495 DOI: 10.1194/Jlr.M006916  0.559
2010 Imaizumi S, Grijalva V, Navab M, Lenten BJV, Wagner AC, Anantharamaiah GM, Fogelman AM, Reddy ST. L-4F Differentially Alters Plasma Levels of Oxidized Fatty Acids Resulting in more Anti-Inflammatory HDL in Mice Drug Metabolism Letters. 4: 139-148. PMID 20642447 DOI: 10.2174/187231210791698438  0.444
2010 Dai L, Datta G, Zhang Z, Gupta H, Patel R, Honavar J, Modi S, Wyss JM, Palgunachari M, Anantharamaiah GM, White CR. The apolipoprotein A-I mimetic peptide 4F prevents defects in vascular function in endotoxemic rats. Journal of Lipid Research. 51: 2695-705. PMID 20495214 DOI: 10.1194/Jlr.M008086  0.449
2010 Kurundkar AR, Killingsworth CR, McIlwain RB, Timpa JG, Hartman YE, He D, Karnatak RK, Neel ML, Clancy JP, Anantharamaiah GM, Maheshwari A. Extracorporeal membrane oxygenation causes loss of intestinal epithelial barrier in the newborn piglet. Pediatric Research. 68: 128-33. PMID 20442689 DOI: 10.1203/Pdr.0B013E3181E4C9F8  0.373
2010 Datta G, Chaddha M, Handattu SP, Palgunachari MN, Nayyar G, Garber DW, Gupta H, White CR, Anantharamaiah GM. ApoE mimetic peptide reduces plasma lipid hydroperoxide content with a concomitant increase in HDL paraoxonase activity Advances in Experimental Medicine and Biology. 660: 1-4. PMID 20221865 DOI: 10.1007/978-1-60761-350-3_1  0.568
2010 Smythies LE, White CR, Maheshwari A, Palgunachari MN, Anantharamaiah GM, Chaddha M, Kurundkar AR, Datta G. Apolipoprotein A-I mimetic 4F alters the function of human monocyte-derived macrophages. American Journal of Physiology. Cell Physiology. 298: C1538-48. PMID 20219948 DOI: 10.1152/Ajpcell.00467.2009  0.447
2010 Buga GM, Navab M, Imaizumi S, Reddy ST, Yekta B, Hough G, Chanslor S, Anantharamaiah GM, Fogelman AM. L-4F Alters Hyperlipidemic (But Not Healthy) Mouse Plasma to Reduce Platelet Aggregation Arteriosclerosis, Thrombosis, and Vascular Biology. 30: 283-289. PMID 19965777 DOI: 10.1161/Atvbaha.109.200162  0.417
2010 McILwain RB, Timpa JG, Kurundkar AR, Holt DW, Kelly DR, Hartman YE, Neel ML, Karnatak RK, Schelonka RL, Anantharamaiah GM, Killingsworth CR, Maheshwari A. Plasma concentrations of inflammatory cytokines rise rapidly during ECMO-related SIRS due to the release of preformed stores in the intestine. Laboratory Investigation; a Journal of Technical Methods and Pathology. 90: 128-39. PMID 19901912 DOI: 10.1038/Labinvest.2009.119  0.366
2010 Datta G, White CR, Dashti N, Chaddha M, Palgunachari MN, Gupta H, Handattu SP, Garber DW, Anantharamaiah GM. Anti-inflammatory and recycling properties of an apolipoprotein mimetic peptide, Ac-hE18A-NH2 Atherosclerosis. 208: 134-141. PMID 19656510 DOI: 10.1016/J.Atherosclerosis.2009.07.019  0.552
2010 Navab M, Shechter I, Anantharamaiah GM, Reddy ST, Lenten BJV, Fogelman AM. Structure and Function of HDL Mimetics Arteriosclerosis, Thrombosis, and Vascular Biology. 30: 164-168. PMID 19608977 DOI: 10.1161/Atvbaha.109.187518  0.577
2010 Handattu SP, Monroe CE, Manchekar MP, Palgunachari M, Groen Tv, Kadish I, Anantharamaiah GM, Garber DW. Mechanism(s) of an apolipoprotein mimetic peptide in inhibitng amyloid plaque deposition- results from in vivo and in vitro studies Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.1951  0.471
2010 White CR, Anantharamaiah GM, Datta G. HDL mimetic peptides: Novel therapeutic strategies for the treatment of inflammatory vascular disease The Hdl Handbook. 179-197. DOI: 10.1016/B978-0-12-382171-3.10009-9  0.474
2009 White CR, Datta G, Mochon P, Zhang Z, Kelly O, Curcio C, Parks D, Palgunachari M, Handattu S, Gupta H, Garber DW, Anantharamaiah GM. Vasculoprotective Effects of Apolipoprotein Mimetic Peptides: An Evolving Paradigm In Hdl Therapy (Vascular Disease Prevention, In Press.). Vascular Disease Prevention. 6: 122-130. PMID 20084185 DOI: 10.2174/1567270000906010122  0.553
2009 Navab M, Anantharamaiah GM, Reddy ST, Lenten BJV, Fogelman AM. HDL as a biomarker, potential therapeutic target, and therapy. Diabetes. 58: 2711-2717. PMID 19940234 DOI: 10.2337/Db09-0538  0.475
2009 Zhang Z, Datta G, Zhang Y, Miller AP, Mochon P, Chen YF, Chatham J, Anantharamaiah GM, White CR. Apolipoprotein A-I mimetic peptide treatment inhibits inflammatory responses and improves survival in septic rats. American Journal of Physiology. Heart and Circulatory Physiology. 297: H866-73. PMID 19561306 DOI: 10.1152/Ajpheart.01232.2008  0.441
2009 Epand RF, Mishra VK, Palgunachari MN, Anantharamaiah GM, Epand RM. Anti-inflammatory peptides grab on to the whiskers of atherogenic oxidized lipids. Biochimica Et Biophysica Acta. 1788: 1967-1975. PMID 19559666 DOI: 10.1016/J.Bbamem.2009.06.015  0.577
2009 Handattu SP, Garber DW, Monroe CE, van Groen T, Kadish I, Nayyar G, Cao D, Palgunachari MN, Li L, Anantharamaiah GM. Oral apolipoprotein A-I mimetic peptide improves cognitive function and reduces amyloid burden in a mouse model of Alzheimer's disease. Neurobiology of Disease. 34: 525-34. PMID 19344763 DOI: 10.1016/J.Nbd.2009.03.007  0.46
2009 Navab M, Ruchala P, Waring AJ, Lehrer RI, Hama S, Hough G, Palgunachari MN, Anantharamaiah GM, Fogelman AM. A novel method for oral delivery of apolipoprotein mimetic peptides synthesized from all L-amino acids Journal of Lipid Research. 50: 1538-1547. PMID 19225094 DOI: 10.1194/Jlr.M800539-Jlr200  0.485
2009 Lenten BJV, Wagner AC, Anantharamaiah GM, Navab M, Reddy ST, Buga GM, Fogelman AM. Apolipoprotein A-I mimetic peptides Current Atherosclerosis Reports. 11: 52-57. PMID 19080728 DOI: 10.1007/S11883-009-0008-8  0.572
2009 Navab M, Reddy ST, Lenten BJV, Anantharamaiah GM, Fogelman AM. The role of dysfunctional HDL in atherosclerosis Journal of Lipid Research. 50. PMID 18955731 DOI: 10.1194/Jlr.R800036-Jlr200  0.495
2008 Van Lenten BJ, Navab M, Anantharamaiah GM, Buga GM, Reddy ST, Fogelman AM. Multiple indications for anti-inflammatory apolipoprotein mimetic peptides. Current Opinion in Investigational Drugs (London, England : 2000). 9: 1157-62. PMID 18951294  0.402
2008 Mishra VK, Palgunachari MN, Krishna R, Glushka J, Segrest JP, Anantharamaiah GM. Effect of leucine to phenylalanine substitution on the nonpolar face of a class A amphipathic helical peptide on its interaction with lipid: high resolution solution NMR studies of 4F-dimyristoylphosphatidylcholine discoidal complex. The Journal of Biological Chemistry. 283: 34393-402. PMID 18845546 DOI: 10.1074/Jbc.M806384200  0.517
2008 White CR, Datta G, Zhang Z, Gupta H, Garber DW, Mishra VK, Palgunachari MN, Handattu SP, Chaddha M, Anantharamaiah GM. HDL therapy for cardiovascular diseases: the road to HDL mimetics. Current Atherosclerosis Reports. 10: 405-12. PMID 18706282 DOI: 10.1007/S11883-008-0063-6  0.477
2008 Van Lenten BJ, Wagner AC, Jung CL, Ruchala P, Waring AJ, Lehrer RI, Watson AD, Hama S, Navab M, Anantharamaiah GM, Fogelman AM. Anti-inflammatory apoA-I-mimetic peptides bind oxidized lipids with much higher affinity than human apoA-I Journal of Lipid Research. 49: 2302-2311. PMID 18621920 DOI: 10.1194/Jlr.M800075-Jlr200  0.5
2008 Navab M, Anantharamaiah GM, Reddy ST, Lenten BJV, Fogelman AM. Apo A-1 mimetic peptides as atheroprotective agents in murine models. Current Drug Targets. 9: 204-209. PMID 18336238 DOI: 10.2174/138945008783755584  0.544
2008 Navab M, Anantharamaiah GM, Fogelman AM. The Effect of Apolipoprotein Mimetic Peptides in Inflammatory Disorders Other than Atherosclerosis Trends in Cardiovascular Medicine. 18: 61-66. PMID 18308197 DOI: 10.1016/J.Tcm.2007.12.006  0.482
2008 Navab M, Yu R, Gharavi N, Huang W, Ezra N, Lotfizadeh A, Anantharamaiah GM, Alipour N, Van Lenten BJ, Reddy ST, Marelli D. High-density lipoprotein: antioxidant and anti-inflammatory properties. Current Atherosclerosis Reports. 9: 244-8. PMID 18241620 DOI: 10.1007/S11883-007-0026-3  0.475
2008 Buga GM, Frank JS, Mottino GA, Hakhamian A, Narasimha A, Watson AD, Yekta B, Navab M, Reddy ST, Anantharamaiah GM, Fogelman AM. D-4F reduces EO6 immunoreactivity, SREBP-1c mRNA levels, and renal inflammation in LDL receptor-null mice fed a Western diet. Journal of Lipid Research. 49: 192-205. PMID 17925450 DOI: 10.1194/Jlr.M700433-Jlr200  0.447
2008 Handattu SP, Garber DW, Monroe CE, Groen Tv, Kadisha I, Mayakonda P, Li L, Anantharamaiah GM. P2-299: Oral administration of an apolipoprotein A-I–mimetic peptide improves cognitive function and reduces amyloid burden in a mouse model of Alzheimer disease Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.1375  0.435
2007 Navab M, Anantharamaiah GM, Reddy ST, Lenten BJV, Buga GM, Fogelman AM. Peptide Mimetics of Apolipoproteins Improve HDL Function. Journal of Clinical Lipidology. 1: 142-147. PMID 18449337 DOI: 10.1016/J.Jacl.2007.03.002  0.507
2007 Lenten BJV, Wagner AC, Navab M, Anantharamaiah GM, Hama S, Reddy ST, Fogelman AM. Lipoprotein inflammatory properties and serum amyloid A levels but not cholesterol levels predict lesion area in cholesterol-fed rabbits. Journal of Lipid Research. 48: 2344-2353. PMID 17693626 DOI: 10.1194/Jlr.M700138-Jlr200  0.468
2007 Anantharamaiah GM, Mishra VK, Garber DW, Datta G, Handattu SP, Palgunachari MN, Chaddha M, Navab M, Reddy ST, Segrest JP, Fogelman AM. Structural requirements for antioxidative and anti-inflammatory properties of apolipoprotein A-I mimetic peptides Journal of Lipid Research. 48: 1915-1923. PMID 17570869 DOI: 10.1194/Jlr.R700010-Jlr200  0.565
2007 Handattu SP, Garber DW, Horn DC, Hughes DW, Berno B, Bain AD, Mishra VK, Palgunachari MN, Datta G, Anantharamaiah GM, Epand RM. ApoA-I mimetic peptides with differing ability to inhibit atherosclerosis also exhibit differences in their interactions with membrane bilayers Journal of Biological Chemistry. 282: 1980-1988. PMID 17114186 DOI: 10.1074/Jbc.M606231200  0.518
2006 Navab M, Anantharamaiah G, Reddy ST, Fogelman AM. Apolipoprotein A-I mimetic peptides and their role in atherosclerosis prevention. Nature Reviews Cardiology. 3: 540-547. PMID 16990839 DOI: 10.1038/Ncpcardio0661  0.573
2006 Navab M, Anantharamaiah GM, Reddy ST, Lenten BJV, Ansell BJ, Fogelman AM. Mechanisms of Disease: proatherogenic HDL—an evolving field Nature Clinical Practice Endocrinology & Metabolism. 2: 504-511. PMID 16957764 DOI: 10.1038/Ncpendmet0245  0.473
2006 Garber DW, Handattu SP, Datta G, Mishra VK, Gupta H, White CR, Anantharamaiah GM. Atherosclerosis and vascular disease: Effects of peptide mimetics of apolilpoproteins Current Pharmaceutical Biotechnology. 7: 235-240. PMID 16918400 DOI: 10.2174/138920106777950834  0.574
2006 Buga GM, Frank JS, Mottino GA, Hendizadeh M, Hakhamian A, Tillisch JH, Reddy ST, Navab M, Anantharamaiah GM, Ignarro LJ, Fogelman AM. D-4F decreases brain arteriole inflammation and improves cognitive performance in LDL receptor-null mice on a Western diet Journal of Lipid Research. 47: 2148-2160. PMID 16835442 DOI: 10.1194/Jlr.M600214-Jlr200  0.576
2006 Navab M, Anantharamaiah GM, Reddy ST, Van Lenten BJ, Datta G, Garber D, Fogelman AM. Potential clinical utility of high-density lipoprotein-mimetic peptides Current Opinion in Lipidology. 17: 440-444. PMID 16832169 DOI: 10.1097/01.Mol.0000236371.27508.D4  0.537
2006 Anantharamaiah GM, Navab M, Reddy ST, Garber DW, Datta G, Gupta H, White CR, Handattu SP, Palgunachari MN, Chaddha M, Mishra VK, Segrest JP, Fogelman AM. Synthetic peptides: Managing lipid disorders Current Opinion in Lipidology. 17: 233-237. PMID 16680027 DOI: 10.1097/01.Mol.0000226114.89812.75  0.527
2006 Ajees AA, Anantharamaiah GM, Mishra VK, Hussain MM, Murthy HM. Crystal structure of human apolipoprotein A-I: insights into its protective effect against cardiovascular diseases. Proceedings of the National Academy of Sciences of the United States of America. 103: 2126-31. PMID 16452169 DOI: 10.1073/Pnas.0506877103  0.45
2006 Mishra VK, Anantharamaiah GM, Segrest JP, Palgunachari MN, Chaddha M, Sham SWS, Krishna NR. Association of a Model Class A (Apolipoprotein) Amphipathic α Helical Peptide with Lipid HIGH RESOLUTION NMR STUDIES OF PEPTIDE·LIPID DISCOIDAL COMPLEXES Journal of Biological Chemistry. 281: 6511-6519. PMID 16407255 DOI: 10.1074/Jbc.M511475200  0.566
2006 Reddy ST, Anantharamaiah GM, Navab M, Hama S, Hough G, Grijalva V, Garber DW, Datta G, Fogelman AM. Oral amphipathic peptides as therapeutic agents Expert Opinion On Investigational Drugs. 15: 13-21. PMID 16370930 DOI: 10.1517/13543784.15.1.13  0.54
2006 Tang C, Vaughan AM, Anantharamaiah GM, Oram JF. Janus kinase 2 modulates the lipid-removing but not protein-stabilizing interactions of amphipathic helices with ABCA1. Journal of Lipid Research. 47: 107-14. PMID 16210729 DOI: 10.1194/Jlr.M500240-Jlr200  0.576
2006 Gupta H, Zhang Z, Dai L, Honavar J, Anantharamaiah G, White C. We-W32:7 Apolipoprotein A-I mimetic peptide L-4F, prevents lipopolysaccharide-induced changes in vascular function Atherosclerosis Supplements. 7: 310. DOI: 10.1016/S1567-5688(06)81245-6  0.421
2005 Navab M, Anantharamaiah GM, Fogelman AM. An Apolipoprotein A-I Mimetic Works Best in the Presence of Apolipoprotein A-I Circulation Research. 97: 1085-1086. PMID 16306451 DOI: 10.1161/01.Res.0000194558.86099.Ba  0.522
2005 Navab M, Anantharamaiah GM, Reddy ST, Hama S, Hough G, Frank JS, Grijalva VR, Ganesh VK, Mishra VK, Palgunachari MN, Fogelman AM. Oral Small Peptides Render HDL Antiinflammatory in Mice and Monkeys and Reduce Atherosclerosis in ApoE Null Mice Circulation Research. 97: 524-532. PMID 16100046 DOI: 10.1161/01.Res.0000181229.69508.2F  0.574
2005 Navab M, Anantharamaiah GM, Fogelman AM. The role of high-density lipoprotein in inflammation. Trends in Cardiovascular Medicine. 15: 158-161. PMID 16099381 DOI: 10.1016/J.Tcm.2005.05.008  0.477
2005 Gupta H, Dai L, Datta G, Garber DW, Grenett H, Li Y, Mishra V, Palgunachari MN, Handattu S, Gianturco SH, Bradley WA, Anantharamaiah GM, White CR. Inhibition of lipopolysaccharide-induced inflammatory responses by an apolipoprotein AI mimetic peptide. Circulation Research. 97: 236-43. PMID 16002747 DOI: 10.1161/01.Res.0000176530.66400.48  0.487
2005 Navab M, Anantharamaiah GM, Reddy ST, Van Lenten BJ, Wagner AC, Hama S, Hough G, Bachini E, Garber DW, Mishra VK, Palgunachari MN, Fogelman AM. An oral apoJ peptide renders HDL antiinflammatory in mice and monkeys and dramatically reduces atherosclerosis in apolipoprotein E-null mice Arteriosclerosis, Thrombosis, and Vascular Biology. 25: 1932-1937. PMID 15961700 DOI: 10.1161/01.Atv.0000174589.70190.E2  0.465
2005 Gupta H, White CR, Handattu S, Garber DW, Datta G, Chaddha M, Dai L, Gianturco SH, Bradley WA, Anantharamaiah GM. Apolipoprotein E mimetic Peptide dramatically lowers plasma cholesterol and restores endothelial function in watanabe heritable hyperlipidemic rabbits. Circulation. 111: 3112-8. PMID 15939819 DOI: 10.1161/Circulationaha.104.497107  0.525
2005 Navab M, Anantharamaiah GM, Hama S, Hough G, Reddy ST, Frank JS, Garber DW, Handattu S, Fogelman AM. D-4F and statins synergize to render HDL antiinflammatory in mice and monkeys and cause lesion regression in old apolipoprotein E-null mice Arteriosclerosis, Thrombosis, and Vascular Biology. 25: 1426-1432. PMID 15845909 DOI: 10.1161/01.Atv.0000167412.98221.1A  0.408
2005 Navab M, Anantharamaiah GM, Reddy ST, Hama S, Hough G, Grijalva VR, Yu N, Ansell BJ, Datta G, Garber DW, Fogelman AM. Apolipoprotein A-I mimetic peptides - ATVB in focus Arteriosclerosis, Thrombosis, and Vascular Biology. 25: 1325-1331. PMID 15831812 DOI: 10.1161/01.Atv.0000165694.39518.95  0.596
2005 Navab M, Anantharamaiah GM, Reddy ST, Fogelman AM. ApoA-I Mimetic Peptides as Anti-Inflammatory Agents Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents. 5: 335-338. DOI: 10.2174/1568013054637740  0.471
2004 Van Lenten BJ, Wagner AC, Navab M, Anantharamaiah GM, Hui EK, Nayak DP, Fogelman AM. D-4F, an apolipoprotein A-I mimetic peptide, inhibits the inflammatory response induced by influenza A infection of human type II pneumocytes. Circulation. 110: 3252-8. PMID 15533864 DOI: 10.1161/01.Cir.0000147232.75456.B3  0.49
2004 Navab M, Anantharamaiah GM, Reddy ST, Van Lenten BJ, Datta G, Garber D, Fogelman AM. Human apolipoprotein A-I and A-I mimetic peptides: Potential for atherosclerosis reversal Current Opinion in Lipidology. 15: 645-649. PMID 15529023 DOI: 10.1097/00041433-200412000-00004  0.558
2004 Li L, Chen J, Mishra VK, Kurtz JA, Cao D, Klon AE, Harvey SC, Anantharamaiah GM, Segrest JP. Double belt structure of discoidal high density lipoproteins: molecular basis for size heterogeneity. Journal of Molecular Biology. 343: 1293-311. PMID 15491614 DOI: 10.1016/J.Jmb.2004.09.017  0.388
2004 Barter PJ, Nicholls S, Rye KA, Anantharamaiah GM, Navab M, Fogelman AM. Antiinflammatory Properties of HDL Circulation Research. 95: 764-772. PMID 15486323 DOI: 10.1161/01.Res.0000146094.59640.13  0.469
2004 Vedhachalam C, Liu L, Nickel M, Dhanasekaran P, Anantharamaiah GM, Lund-Katz S, Rothblat GH, Phillips MC. Influence of ApoA-I structure on the ABCA1-mediated efflux of cellular lipids. The Journal of Biological Chemistry. 279: 49931-9. PMID 15383537 DOI: 10.1074/Jbc.M406924200  0.477
2004 Epand RM, Epand RF, Sayer BG, Datta G, Chaddha M, Anantharamaiah GM. Two homologous apolipoprotein AI mimetic peptides. Relationship between membrane interactions and biological activity. Journal of Biological Chemistry. 279: 51404-51414. PMID 15358763 DOI: 10.1074/Jbc.M408581200  0.539
2004 Bergt C, Pennathur S, Fu X, Byun J, O'Brien K, McDonald TO, Singh P, Anantharamaiah GM, Chait A, Brunzell J, Geary RL, Oram JF, Heinecke JW. The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport. Proceedings of the National Academy of Sciences of the United States of America. 101: 13032-7. PMID 15326314 DOI: 10.1073/Pnas.0405292101  0.465
2004 Dashti N, Datta G, Manchekar M, Chaddha M, Anantharamaiah GM. Model class A and class L peptides increase the production of apoA-I-containing lipoproteins in HepG2 cells. Journal of Lipid Research. 45: 1919-1928. PMID 15292373 DOI: 10.1194/Jlr.M400251-Jlr200  0.561
2004 Navab M, Anantharamaiah GM, Reddy ST, Hama S, Hough G, Grijalva VR, Wagner AC, Frank JS, Datta G, Garber D, Fogelman AM. Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice Circulation. 109: 3215-3220. PMID 15197147 DOI: 10.1161/01.Cir.0000134275.90823.87  0.497
2004 Epand RM, Epand RF, Sayer BG, Melacini G, Palgulachari MN, Segrest JP, Anantharamaiah GM. An Apolipoprotein AI Mimetic Peptide: Membrane Interactions and the Role of Cholesterol Biochemistry. 43: 5073-5083. PMID 15109266 DOI: 10.1021/Bi049786U  0.58
2004 Datta G, Epand RF, Epand RM, Chaddha M, Kirksey MA, Garber DW, Lund-Katz S, Phillips MC, Hama S, Navab M, Fogelman AM, Palgunachari MN, Segrest JP, Anantharamaiah GM. Aromatic residue position on the nonpolar face of class a amphipathic helical peptides determines biological activity. The Journal of Biological Chemistry. 279: 26509-17. PMID 15075321 DOI: 10.1074/Jbc.M314276200  0.499
2004 Kockx M, Rye KA, Gaus K, Quinn CM, Wright J, Sloane T, Sviridov D, Fu Y, Sullivan D, Burnett JR, Rust S, Assmann G, Anantharamaiah GM, Palgunachari MN, Katz SL, et al. Apolipoprotein A-I-stimulated apolipoprotein E secretion from human macrophages is independent of cholesterol efflux. The Journal of Biological Chemistry. 279: 25966-77. PMID 15066991 DOI: 10.1074/Jbc.M401177200  0.474
2003 Navab M, Anantharamaiah GM, Reddy ST, Van Lenten BJ, Hough G, Wagner A, Nakamura K, Garber DW, Datta G, Segrest JP, Hama S, Fogelman AM. Human apolipoprotein AI mimetic peptides for the treatment of atherosclerosis Current Opinion in Investigational Drugs. 4: 1100-1104. PMID 14582455  0.448
2003 Garber DW, Handattu S, Aslan I, Datta G, Chaddha M, Anantharamaiah GM. Effect of an arginine-rich amphipathic helical peptide on plasma cholesterol in dyslipidemic mice Atherosclerosis. 168: 229-237. PMID 12801605 DOI: 10.1016/S0021-9150(03)00101-1  0.547
2003 Thuahnai ST, Lund-Katz S, Anantharamaiah GM, Williams DL, Phillips MC. A quantitative analysis of apolipoprotein binding to SR-BI: multiple binding sites for lipid-free and lipid-associated apolipoproteins. Journal of Lipid Research. 44: 1132-42. PMID 12671027 DOI: 10.1194/Jlr.M200429-Jlr200  0.485
2002 Segall ML, Dhanasekaran P, Baldwin F, Anantharamaiah GM, Weisgraber KH, Phillips MC, Lund-Katz S. Influence of apoE domain structure and polymorphism on the kinetics of phospholipid vesicle solubilization. Journal of Lipid Research. 43: 1688-700. PMID 12364553 DOI: 10.1194/Jlr.M200157-Jlr200  0.408
2002 Van Lenten BJ, Wagner AC, Anantharamaiah GM, Garber DW, Fishbein MC, Adhikary L, Nayak DP, Hama S, Navab M, Fogelman AM. Influenza infection promotes macrophage traffic into arteries of mice that is prevented by D-4F, an apolipoprotein A-I mimetic peptide. Circulation. 106: 1127-32. PMID 12196340 DOI: 10.1161/01.Cir.0000030182.35880.3E  0.433
2002 Ramprasad MP, Anantharamaiah GM, Garber DW, Katre NV. Sustained-delivery of an apolipoproteinE-peptidomimetic using multivesicular liposomes lowers serum cholesterol levels Journal of Controlled Release. 79: 207-218. PMID 11853932 DOI: 10.1016/S0168-3659(01)00552-1  0.558
2002 Navab M, Anantharamaiah GM, Hama S, Garber DW, Chaddha M, Hough G, Lallone R, Fogelman AM. Oral administration of an apo A-I mimetic peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol Circulation. 105: 290-292. PMID 11804981 DOI: 10.1161/Hc0302.103711  0.538
2002 Segrest JP, Jones MK, Mishra VK, Anantharamaiah GM. Experimental and computational studies of the interactions of amphipathic peptides with lipid surfaces Current Topics in Membranes. 52: 397-435. DOI: 10.1016/S1063-5823(02)52016-0  0.502
2001 Polozov IV, Anantharamaiah GM, Segrest JP, Epand RM. Osmotically Induced Membrane Tension Modulates Membrane Permeabilization by Class L Amphipathic Helical Peptides: Nucleation Model of Defect Formation Biophysical Journal. 81: 949-959. PMID 11463637 DOI: 10.1016/S0006-3495(01)75753-0  0.509
2001 Datta G, Chaddha M, Hama S, Navab M, Fogelman AM, Garber DW, Mishra VK, Epand RM, Epand RF, Lund-Katz S, Phillips MC, Segrest JP, Anantharamaiah GM. Effects of increasing hydrophobicity on the physical-chemical and biological properties of a class A amphipathic helical peptide Journal of Lipid Research. 42: 1096-1104. PMID 11441137  0.453
2001 Datta G, Garber DW, Chung BH, Chaddha M, Dashti N, Bradley WA, Gianturco SH, Anantharamaiah GM. Cationic domain 141-150 of apoE covalently linked to a class A amphipathic helix enhances atherogenic lipoprotein metabolism in vitro and in vivo. Journal of Lipid Research. 42: 959-66. PMID 11369804  0.504
2001 Mishra VK, Palgunachari MN, Anantharamaiah GM, Jones MK, Segrest JP, Krishna NR. Solution NMR structure of a model class A (apolipoprotein) amphipathic α helical peptide Peptides. 22: 567-573. PMID 11311725 DOI: 10.1016/S0196-9781(01)00365-5  0.449
2001 Garber DW, Datta G, Chaddha M, Palgunachari MN, Hama SY, Navab M, Fogelman AM, Segrest JP, Anantharamaiah GM. A new synthetic class A amphipathic peptide analogue protects mice from diet-induced atherosclerosis. Journal of Lipid Research. 42: 545-52. PMID 11290826  0.46
2001 Brouillette CG, Anantharamaiah GM, Engler JA, Borhani DW. Structural models of human apolipoprotein A-I: a critical analysis and review. Biochimica Et Biophysica Acta. 1531: 4-46. PMID 11278170 DOI: 10.1016/S1388-1981(01)00081-6  0.466
2001 Boggs JM, Jo E, Polozov IV, Epand RF, Anantharamaiah GM, Blazyk J, Epand RM. Effect of magainin, class L, and class A amphipathic peptides on fatty acid spin labels in lipid bilayers. Biochimica Et Biophysica Acta. 1511: 28-41. PMID 11248202 DOI: 10.1016/S0005-2736(00)00379-5  0.529
2001 Lee YC, Jackson PL, Jablonsky MJ, Muccio DD, Pfister RR, Haddox JL, Sommers CI, Anantharamaiah GM, Chaddha M. NMR conformational analysis of cis and trans proline isomers in the neutrophil chemoattractant, N-acetyl-proline-glycine-proline. Biopolymers. 58: 548-61. PMID 11246204 DOI: 10.1002/1097-0282(200105)58:6<548::Aid-Bip1030>3.0.Co;2-B  0.418
2000 Navab M, Hama SY, Anantharamaiah GM, Hassan K, Hough GP, Watson AD, Reddy ST, Sevanian A, Fonarow GC, Fogelman AM. Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: steps 2 and 3. Journal of Lipid Research. 41: 1495-508. PMID 10974057  0.364
2000 Navab M, Hama SY, Cooke CJ, Anantharamaiah GM, Chaddha M, Jin L, Subbanagounder G, Faull KF, Reddy ST, Miller NE, Fogelman AM. Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1. Journal of Lipid Research. 41: 1481-94. PMID 10974056  0.355
2000 Williams DL, de La Llera-Moya M, Thuahnai ST, Lund-Katz S, Connelly MA, Azhar S, Anantharamaiah GM, Phillips MC. Binding and cross-linking studies show that scavenger receptor BI interacts with multiple sites in apolipoprotein A-I and identify the class A amphipathic alpha-helix as a recognition motif. The Journal of Biological Chemistry. 275: 18897-904. PMID 10858447 DOI: 10.1074/Jbc.M002411200  0.462
2000 Garber DW, Kulkarni KR, Anantharamaiah GM. A sensitive and convenient method for lipoprotein profile analysis of individual mouse plasma samples. Journal of Lipid Research. 41: 1020-6. PMID 10828095  0.329
2000 Segrest JP, Li L, Anantharamaiah GM, Harvey SC, Liadaki KN, Zannis V. Structure and function of apolipoprotein A-I and high-density lipoprotein. Current Opinion in Lipidology. 11: 105-15. PMID 10787171 DOI: 10.1097/00041433-200004000-00002  0.444
2000 Datta G, Chaddha M, Garber DW, Chung BH, Tytler EM, Dashti N, Bradley WA, Gianturco SH, Anantharamaiah GM. The receptor binding domain of apolipoprotein E, linked to a model class A amphipathic helix, enhances internalization and degradation of LDL by fibroblasts. Biochemistry. 39: 213-20. PMID 10625496 DOI: 10.1021/Bi991209W  0.523
1999 Haddox JL, Pfister RR, Muccio DD, Villain M, Sommers CI, Chaddha M, Anantharamaiah GM, Brouillette WJ, DeLucas LJ. Bioactivity of peptide analogs of the neutrophil chemoattractant, N- acetyl-proline-glycine-proline Investigative Ophthalmology and Visual Science. 40: 2427-2429. PMID 10476813  0.396
1999 Handwerger S, Datta G, Richardson B, Schmidt CM, Siddiqi T, Turzai L, Anantharamaiah GM. Pre-β-HDL stimulates placental lactogen release from human trophoblast cells American Journal of Physiology-Endocrinology and Metabolism. 276. PMID 9950800 DOI: 10.1152/Ajpendo.1999.276.2.E384  0.376
1999 Gillotte KL, Zaiou M, Lund-Katz S, Anantharamaiah GM, Holvoet P, Dhoest A, Palgunachari MN, Segrest JP, Weisgraber KH, Rothblat GH, Phillips MC. Apolipoprotein-mediated plasma membrane microsolubilization. Role of lipid affinity and membrane penetration in the efflux of cellular cholesterol and phospholipid. The Journal of Biological Chemistry. 274: 2021-8. PMID 9890960 DOI: 10.1074/Jbc.274.4.2021  0.547
1998 Rogers DP, Roberts LM, Lebowitz J, Datta G, Anantharamaiah GM, Engler JA, Brouillette CG. The lipid-free structure of apolipoprotein A-I: effects of amino-terminal deletions. Biochemistry. 37: 11714-25. PMID 9718294 DOI: 10.1021/Bi973112K  0.473
1998 Mishra VK, Palgunachari MN, Datta G, Phillips MC, Lund-Katz S, Adeyeye SO, Segrest JP, Anantharamaiah GM. Studies of synthetic peptides of human apolipoprotein A-I containing tandem amphipathic α-helixes Biochemistry. 37: 10313-10324. PMID 9665740 DOI: 10.1021/Bi980042O  0.562
1998 Polozov IV, Polozova AI, Mishra VK, Anantharamaiah GM, Segrest JP, Epand RM. Studies of kinetics and equilibrium membrane binding of class A and class L model amphipathic peptides. Biochimica Et Biophysica Acta. 1368: 343-354. PMID 9459611 DOI: 10.1016/S0005-2736(97)00210-1  0.547
1997 Gazzara JA, Phillips MC, Lund-Katz S, Palgunachari MN, Segrest JP, Anantharamaiah GM, Rodrigueza WV, Snow JW. Effect of vesicle size on their interaction with class A amphipathic helical peptides. Journal of Lipid Research. 38: 2147-54. PMID 9374136  0.396
1997 Gazzara JA, Phillips MC, Lund-Katz S, Palgunachari MN, Segrest JP, Anantharamaiah GM, Snow JW. Interaction of class A amphipathic helical peptides with phospholipid unilamellar vesicles. Journal of Lipid Research. 38: 2134-46. PMID 9374135  0.424
1997 Polozov IV, Polozova AI, Tytler EM, Anantharamaiah GM, Segrest JP, Woolley GA, Epand RM. Role of Lipids in the Permeabilization of Membranes by Class L Amphipathic Helical Peptides Biochemistry. 36: 9237-9245. PMID 9230057 DOI: 10.1021/Bi970045L  0.477
1997 Rogers DP, Brouillette CG, Engler JA, Tendian SW, Roberts L, Mishra VK, Anantharamaiah GM, Lund-Katz S, Phillips MC, Ray MJ. Truncation of the amino terminus of human apolipoprotein A-I substantially alters only the lipid-free conformation. Biochemistry. 36: 288-300. PMID 9003180 DOI: 10.1021/Bi961876E  0.48
1997 Chung BH, Palgunachari MN, Mishra VK, Chang CH, Segrest JP, Anantharamaiah GM. Probing structure and function of VLDL by synthetic amphipathic helical peptides. Journal of Lipid Research. 37: 1099-112. PMID 8725161  0.474
1996 Anantharamaiah GM, Garber DW. Chromatographic Methods For Quantitation Of Apolipoprotein A-I Methods in Enzymology. 263: 267-282. PMID 8749014 DOI: 10.1016/S0076-6879(96)63019-5  0.388
1996 Richardson B, Palgunachari MN, Anantharamaiah GM, Richards RG, Azrolan N, Wiginton D, Handwerger S. Human placental tissue expresses a novel 22.7 kDa apolipoprotein A-I-like protein. Biochemistry. 35: 7580-5. PMID 8652539 DOI: 10.1021/bi9526950  0.292
1996 Palgunachari MN, Mishra VK, Lund-Katz S, Phillips MC, Adeyeye SO, Alluri S, Anantharamaiah GM, Segrest JP. Only the two end helixes of eight tandem amphipathic helical domains of human Apo A-I have significant lipid affinity: Implications for HDL assembly Arteriosclerosis, Thrombosis, and Vascular Biology. 16: 328-338. PMID 8620350 DOI: 10.1161/01.Atv.16.2.328  0.537
1995 Sparks DL, Anantharamaiah GM, Segrest JP, Phillips MC. Effect of the cholesterol content of reconstituted LpA-I on lecithin:cholesterol acyltransferase activity. The Journal of Biological Chemistry. 270: 5151-7. PMID 7890624 DOI: 10.1074/Jbc.270.10.5151  0.455
1995 Mishra VK, Palgunachari MN, Lund-Katz S, Phillips MC, Segrest JP, Anantharamaiah GM. Effect of the arrangement of tandem repeating units of class A amphipathic α-helixes on lipid interaction Journal of Biological Chemistry. 270: 1602-1611. PMID 7829491 DOI: 10.1074/Jbc.270.4.1602  0.423
1995 Polozov IV, Polozova AI, Anantharamaiah GM, Segrest JP, Epand RM. Mixing rates can markedly affect the kinetics of peptide-induced leakage from liposomes. Biochemistry and Molecular Biology International. 33: 1073-9. PMID 7804132  0.44
1995 Yancey PG, Bielicki JK, Johnson WJ, Lund-Katz S, Palgunachari MN, Anantharamaiah GM, Segrest JP, Phillips MC, Rothblat GH. Efflux of cellular cholesterol and phospholipid to lipid-free apolipoproteins and class A amphipathic peptides Biochemistry. 34: 7955-7965. PMID 7794908 DOI: 10.1021/Bi00024A021  0.539
1995 Brouillette CG, Anantharamaiah GM. Structural models of human apolipoprotein A-I☆ Biochimica Et Biophysica Acta. 1256: 103-129. PMID 7766689 DOI: 10.1016/0005-2760(95)00018-8  0.348
1995 Tytler EM, Anantharamaiah GM, Walker DE, Mishra VK, Palgunachari MN, Segrest JP. Molecular basis for prokaryotic specificity of magainin-induced lysis. Biochemistry. 34: 4393-401. PMID 7703253 DOI: 10.1021/Bi00013A031  0.55
1995 Clay MA, Anantharamaiah GM, Mistry MJ, Balasubramaniam A, Harmony JA. Localization of a domain in apolipoprotein E with both cytostatic and cytotoxic activity. Biochemistry. 34: 11142-51. PMID 7669772 DOI: 10.1021/Bi00035A020  0.545
1995 Epand RM, Shai Y, Segrest JP, Anantharamaiah GM. Mechanisms for the modulation of membrane bilayer properties by amphipathic helical peptides. Biopolymers. 37: 319-38. PMID 7632881 DOI: 10.1002/Bip.360370504  0.403
1995 Lund-Katz S, Phillips MC, Mishra VK, Segrest JP, Anantharamaiah GM. Microenvironments of basic amino acids in amphipathic α-helices bound to phospholipid: 13C NMR studies using selectively labeled peptides Biochemistry. 34: 9219-9226. PMID 7619823 DOI: 10.1021/Bi00028A035  0.494
1994 Segrest JP, Garber DW, Brouillette CG, Harvey SC, Anantharamaiah GM. The amphipathic alpha helix: a multifunctional structural motif in plasma apolipoproteins. Advances in Protein Chemistry. 45: 303-69. PMID 8154372 DOI: 10.1016/S0065-3233(08)60643-9  0.456
1994 Chung BH, Tallis G, Yalamoori V, Anantharamaiah GM, Segrest JP. Liposome-like particles isolated from human atherosclerotic plaques are structurally and compositionally similar to surface remnants of triglyceride-rich lipoproteins. Arteriosclerosis, Thrombosis, and Vascular Biology. 14: 622-635. PMID 8148360 DOI: 10.1161/01.Atv.14.4.622  0.452
1994 Mishra VK, Palgunachari MN, Segrest JP, Anantharamaiah GM. Interactions of synthetic peptide analogs of the class A amphipathic helix with lipids. Evidence for the snorkel hypothesis. The Journal of Biological Chemistry. 269: 7185-91. PMID 8125930  0.399
1994 Davidson WS, Lund-Katz S, Johnson WJ, Anantharamaiah GM, Palgunachari MN, Segrest JP, Rothblat GH, Phillips MC. The influence of apolipoprotein structure on the efflux of cellular free cholesterol to high density lipoprotein Journal of Biological Chemistry. 269: 22975-22982. PMID 8083197  0.489
1994 Epand RM, Stafford A, Leon B, Lock PE, Tytler EM, Segrest JP, Anantharamaiah GM. HDL and apolipoprotein A-I protect erythrocytes against the generation of procoagulant activity. Arteriosclerosis, Thrombosis, and Vascular Biology. 14: 1775-1783. PMID 7947603 DOI: 10.1161/01.Atv.14.11.1775  0.451
1994 Mendez AJ, Anantharamaiah GM, Segrest JP, Oram JF. Synthetic amphipathic helical peptides that mimic apolipoprotein A-I in clearing cellular cholesterol. Journal of Clinical Investigation. 94: 1698-1705. PMID 7929849 DOI: 10.1172/Jci117515  0.558
1994 Spuhler P, Anantharamaiah GM, Segrest JP, Seelig J. Binding of apolipoprotein A-I model peptides to lipid bilayers. Measurement of binding isotherms and peptide-lipid headgroup interactions. The Journal of Biological Chemistry. 269: 23904-10. PMID 7929037  0.433
1994 Segrest JP, Anantharamaiah GM. Pathogenesis of atherosclerosis. Current Opinion in Cardiology. 9: 404-10. PMID 7919584  0.371
1994 Segrest JP, Jones MK, Mishra VK, Anantharamaiah GM, Garber DW. apoB-100 has a pentapartite structure composed of three amphipathic alpha-helical domains alternating with two amphipathic beta-strand domains. Detection by the computer program LOCATE. Arteriosclerosis, Thrombosis, and Vascular Biology. 14: 1674-1685. PMID 7918318 DOI: 10.1161/01.Atv.14.10.1674  0.431
1994 Chung BH, Palgunachari MN, Mishra VK, Chang R, Anantharamaiah GM. Probing structure and function of VLDL by synthetic amphipathic peptides Atherosclerosis. 109: 263. DOI: 10.1016/0021-9150(94)94051-7  0.491
1994 Clay MA, Anantharamaiah GM, Balasubramaniam A, Harmony JAK. Structural determinants of apo E peptide cytotoxicity Atherosclerosis. 109: 261. DOI: 10.1016/0021-9150(94)94043-6  0.487
1994 Segrest JP, Jones MK, Mishra VK, Anantharamaiah GM, Garber DW. Potential lipid-associated amphipathic α helixes of apolipoprotein B-100: detection by the computer program LOCATE Atherosclerosis. 109: 138-139. DOI: 10.1016/0021-9150(94)93565-3  0.383
1993 Venkatachalapathi YV, Phillips MC, Epand RM, Epand RF, Tytler EM, Segrest JP, Anantharamaiah GM. Effect of end group blockage on the properties of a class A amphipathic helical peptide Proteins. 15: 349-359. PMID 8460106 DOI: 10.1002/Prot.340150403  0.499
1993 Tytler EM, Segrest JP, Epand RM, Nie SQ, Epand RF, Mishra VK, Venkatachalapathi YV, Anantharamaiah GM. Reciprocal effects of apolipoprotein and lytic peptide analogs on membranes. Cross-sectional molecular shapes of amphipathic alpha helixes control membrane stability. The Journal of Biological Chemistry. 268: 22112-8. PMID 8408070  0.424
1993 Jo H, Radding W, Anantharamaiah GM, McDonald JM. An insulin receptor peptide (1135-1156) stimulates guanosine 5'[γ-thio]triphosphate binding to the 67 kDa G-protein associated with the insulin receptor Biochemical Journal. 294: 19-24. PMID 8363571 DOI: 10.1042/Bj2940019  0.377
1993 Gupta G, Anantharamaiah GM, Scott DR, Eldridge JH, Myers G. Solution structure of the V3 loop of a Thailand HIV isolate. Journal of Biomolecular Structure & Dynamics. 11: 345-366. PMID 8286061 DOI: 10.1080/07391102.1993.10508731  0.349
1993 Srinivas SK, Srinivas RV, Anantharamaiah GM, Compans RW, Segrest JP. Cytosolic domain of the human immunodeficiency virus envelope glycoproteins binds to calmodulin and inhibits calmodulin-regulated proteins. The Journal of Biological Chemistry. 268: 22895-9. PMID 8226798  0.321
1992 Blackburn WD, Dohlman JG, Venkatachalapathi YV, Pillion DJ, Koopman WJ, Segrest JP, Anantharamaiah GM. Apolipoprotein A-I decreases neutrophil degranulation and superoxide production. Journal of Lipid Research. 32: 1911-8. PMID 1667793  0.433
1992 Garber DW, Venkatachalapathi YV, Gupta KB, Ibdah J, Phillips MC, Hazelrig JB, Segrest JP, Anantharamaiah GM. Turnover of synthetic class A amphipathic peptide analogues of exchangeable apolipoproteins in rats. Correlation with physical properties. Arteriosclerosis, Thrombosis, and Vascular Biology. 12: 886-894. PMID 1637786 DOI: 10.1161/01.Atv.12.8.886  0.484
1992 Jones MK, Anantharamaiah GM, Segrest JP. Computer programs to identify and classify amphipathic alpha helical domains. Journal of Lipid Research. 33: 287-96. PMID 1569380  0.325
1992 Segrest JP, Jones MK, De Loof H, Brouillette CG, Venkatachalapathi YV, Anantharamaiah GM. The amphipathic helix in the exchangeable apolipoproteins: a review of secondary structure and function. Journal of Lipid Research. 33: 141-66. PMID 1569369  0.333
1992 Srinivas SK, Srinivas RV, Anantharamaiah GM, Segrest JP, Compans RW. Membrane interactions of synthetic peptides corresponding to amphipathic helical segments of the human immunodeficiency virus type-1 envelope glycoprotein. The Journal of Biological Chemistry. 267: 7121-7. PMID 1551918  0.423
1991 Epand RM, Segrest JP, Anantharamaiah GM. Thermodynamics of the binding of human apolipoprotein A-I to dimyristoylphosphatidylglycerol. The Journal of Biological Chemistry. 265: 20829-32. PMID 2123484  0.321
1991 Anantharamaiah GM, Brouillette CG, Engler JA, De Loof H, Venkatachalapathi YV, Boogaerts J, Segrest JP. Role of amphipathic helixes in HDL structure/function Advances in Experimental Medicine and Biology. 285: 131-140. PMID 1907078 DOI: 10.1007/978-1-4684-5904-3_17  0.398
1991 Srinivas RV, Venkatachalapathi YV, Rui Z, Owens RJ, Gupta KB, Srinivas SK, Anantharamaiah GM, Segrest JP, Compans RW. Inhibition of virus-induced cell fusion by apolipoprotein A-I and its amphipathic peptide analogs. Journal of Cellular Biochemistry. 45: 224-37. PMID 1647394 DOI: 10.1002/Jcb.240450214  0.567
1990 Lund-Katz S, Anantharamaiah GM, Venkatachalapathi YV, Segrest JP, Phillips MC. Nuclear magnetic resonance investigation of the interaction with phospholipid of an amphipathic α-helix-forming peptide of the apolipoprotein class Journal of Biological Chemistry. 265: 12217-12223. PMID 2373689  0.354
1990 Segrest JP, Loof HD, Dohlman JG, Brouillette CG, Anantharamaiah GM. Amphipathic helix motif: Classes and properties Proteins. 8: 103-117. PMID 2235991 DOI: 10.1002/Prot.340080202  0.362
1990 Owens BJ, Anantharamaiah GM, Kahlon JB, Srinivas RV, Compans RW, Segrest JP. Apolipoprotein A-I and its amphipathic helix peptide analogues inhibit human immunodeficiency virus-induced syncytium formation. The Journal of Clinical Investigation. 86: 1142-50. PMID 2170446 DOI: 10.1172/Jci114819  0.414
1990 Srinivas RV, Birkedal B, Owens RJ, Anantharamaiah GM, Segrest JP, Compans RW. Antiviral effects of apolipoprotein A-I and its synthetic amphipathic peptide analogs. Virology. 176: 48-57. PMID 2158697 DOI: 10.1016/0042-6822(90)90229-K  0.478
1990 Liu D, Huang L, Moore MA, Anantharamaiah GM, Segrest JP. Interactions of serum proteins with small unilamellar liposomes composed of dioleoylphosphatidylethanolamine and oleic acid: high-density lipoprotein, apolipoprotein A1, and amphipathic peptides stabilize liposomes. Biochemistry. 29: 3637-3643. PMID 2111162 DOI: 10.1021/Bi00467A008  0.529
1990 Anantharamaiah GM, Venkatachalapathi YV, Brouillette CG, Segrest JP. Use of synthetic peptide analogues to localize lecithin:cholesterol acyltransferase activating domain in apolipoprotein A-I. Arteriosclerosis (Dallas, Tex.). 10: 95-105. PMID 2105091 DOI: 10.1161/01.Atv.10.1.95  0.547
1989 Epand RM, Surewicz WK, Hughes DW, Mantsch H, Segrest JP, Allen TM, Anantharamaiah GM. Properties of lipid complexes with amphipathic helix-forming peptides. Role of distribution of peptide charges. The Journal of Biological Chemistry. 264: 4628-35. PMID 2925658  0.422
1989 Jorgensen EV, Anantharamaiah GM, Segrest JP, Gwynne JT, Handwerger S. Synthetic amphipathic peptides resembling apolipoproteins stimulate the release of human placental lactogen. The Journal of Biological Chemistry. 264: 9215-9. PMID 2722824  0.377
1989 Signas C, Raucci G, Jonsson K, Lindgren PE, Anantharamaiah GM, Hook M, Lindberg M. Nucleotide sequence of the gene for a fibronectin-binding protein from Staphylococcus aureus: use of this peptide sequence in the synthesis of biologically active peptides Proceedings of the National Academy of Sciences of the United States of America. 86: 699-703. PMID 2521391 DOI: 10.1073/Pnas.86.2.699  0.478
1988 Anantharamaiah GM, Hughes TA, Iqbal M, Gawish A, Neame PJ, Medley MF, Segrest JP. Effect of oxidation on the properties of apolipoproteins A-I and A-II. Journal of Lipid Research. 29: 309-18. PMID 3132519  0.414
1987 Malik NA, Anantharamaiah GM, Gawish A, Cheung HC. Structural and biological studies on synthetic peptide analogues of a low-affinity calcium-binding site of skeletal troponin C. Biochimica Et Biophysica Acta. 911: 221-30. PMID 3801495 DOI: 10.1016/0167-4838(87)90011-2  0.493
1987 Epand RM, Gawish A, Iqbal M, Gupta KB, Chen CH, Segrest JP, Anantharamaiah GM. Studies of synthetic peptide analogs of the amphipathic helix. Effect of charge distribution, hydrophobicity, and secondary structure on lipid association and lecithin:cholesterol acyltransferase activation. The Journal of Biological Chemistry. 262: 9389-96. PMID 3597415  0.467
1987 Cheung MC, Segrest JP, Albers JJ, Cone JT, Brouillette CG, Chung BH, Kashyap M, Glasscock MA, Anantharamaiah GM. Characterization of high density lipoprotein subspecies: structural studies by single vertical spin ultracentrifugation and immunoaffinity chromatography. Journal of Lipid Research. 28: 913-29. PMID 3117954  0.329
1987 Esko JD, Weinke JL, Taylor WH, Ekborg G, Rodén L, Anantharamaiah G, Gawish A. Inhibition of chondroitin and heparan sulfate biosynthesis in Chinese hamster ovary cell mutants defective in galactosyltransferase I. The Journal of Biological Chemistry. 262: 12189-95. PMID 2957376  0.211
1986 Anantharamaiah GM. [36] Synthetic peptide analogs of apolipoproteins Methods in Enzymology. 128: 627-647. PMID 3724527 DOI: 10.1016/0076-6879(86)28096-9  0.555
1985 Anantharamaiah GM, Jones JL, Brouillette CG, Schmidt CF, Chung BH, Hughes TA, Bhown AS, Segrest JP. Studies of synthetic peptide analogs of the amphipathic helix. Structure of complexes with dimyristoyl phosphatidylcholine. The Journal of Biological Chemistry. 260: 10248-55. PMID 4019510  0.33
1982 Anantharamaiah GM, Roeske RW. Resolution of α-methyl amino esters by chymotrypsin Tetrahedron Letters. 23: 3335-3336. DOI: 10.1016/S0040-4039(00)87608-X  0.336
1980 Royer GP, Hsiao HY, Anantharamaiah GM. Use of immobilized carboxypeptidase Y (I-CPY) as a catalyst for deblocking in peptide synthesis. Biochimie. 62: 537-41. PMID 7417589 DOI: 10.1016/S0300-9084(80)80098-8  0.739
1979 ElAmin B, Anantharamaiah GM, Royer GP, Means GE. Removal of benzyl-type protecting groups from peptides by catalytic transfer hydrogenation with formic acid The Journal of Organic Chemistry. 44: 3442-3444. DOI: 10.1021/Jo01333A048  0.787
1977 Anantharamaiah GM, Sivanandaiah KM. Transfer hydrogenation; a convenient method for removal of some commonly used protecting groups in peptide synthesis. Journal of the Chemical Society. Perkin Transactions 1. 490-1. PMID 557482 DOI: 10.1039/P19770000490  0.759
1974 Anantharamaiah GM, Sivanandaiah KM. Fibrinopeptides. 3. Synthesis of the protected nonapeptide sequence of fibrinopeptide-B of green monkey. International Journal of Peptide and Protein Research. 6: 51-4. PMID 4213116 DOI: 10.1111/J.1399-3011.1974.Tb02359.X  0.747
Show low-probability matches.